Dr. Antje Willuweit studied Biology at the Technical University of Darmstadt and received her PhD from the Max-Planck-Institute in Bad Nauheim. She gained 9 years of industrial experience in the following Biotech companies: Artemis Pharmaceuticals GmbH, Evotec Neurosciences AG, Evotec AG. In 2011 she joined the Jülich Research Centre at the Institute of Neuroscience and Medicine, where she established her own research group. In total, she has got over 20 years of experience with animal models, including 15 years in the field of preclinical drug testing against Alzheimer´s disease and other neurodegenerative diseases. She is Co-founder of Priavoid GmbH and Director of Preclinical Research.